It takes 20 years to build a reputation and five minutes to ruin it. If you think about that, you'll do things differently. - Warren Buffett
Progenics Pharmaceuticals (PGNX) is a prime example of the need for investors to keep up with investments. I'm correct in my forecast of the Azedra approval. And yet, other fundamental developments were beyond of my preliminary expectation. I strongly believe that most value in Progenics resides in its prostate cancer franchise. To my disappointment, the company reported what I believed to be subpar clinical outcomes for